Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/en/projects/384-a-phase-i-study-of-inotuzumab-ozogamicin-cmc-544-in-combination-with-temsirolimus-cci-779-in-patients-with-relapsed-or-refractory-cd22-positive-b-cell-non-hodgkins-lymphomas